Safety, procedural success and outcome of the Aspirex® S endovascular thrombectomy system in the treatment of iliofemoral deep vein thrombosis - data from the Arnsberg Aspirex registry

VASA. Zeitschrift für Gefässkrankheiten
Michael LichtenbergFrank Breuckmann

Abstract

Background: Percutaneous mechanical thrombectomy (PMT) represents a treatment option in addition to conventional therapy for patients with iliofemoral deep vein thrombosis (DVT). We sought to determine the safety, patency and short-term outcome of the Aspirex®S catheter as a rotational mechanical thrombectomy device in the endovascular treatment of iliofemoral DVT. Patients and methods: 56 patients (66 % female, median age 51 years) undergoing mechanical thrombectomy with the Aspirex®S catheter for endovascular treatment of iliofemoral DVT were included in the analysis. Device- and procedure-related complications, prevention of post-thrombotic syndrome (PTS) and patency rates were determined at baseline and at 1, 6 and 12 months after intervention. Results: No device-related complications or malfunction occurred. Procedure-related complications (rehospitalization, re-occlusion of target vein, prolonged hospitalization resulting from access site complication) were seen in 14 % of patients. PMT was followed by implantation of a dedicated venous stent in all patients. Low PTS reflected by a revised venous clinical severity score (rVCSS) of < 3 and a clinical, etiologic, anatomic and pathophysiologic (CEAP) score of < 3 were achiev...Continue Reading

References

Jul 1, 1996·Annals of Internal Medicine·P PrandoniM H Prins
Dec 29, 2004·Journal of Vascular Surgery·Bo EklöfUNKNOWN American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification
Sep 6, 2008·Journal of Vascular Surgery·Peter NeglénSeshadri Raju
Feb 19, 2009·British Journal of Haematology·Paolo Prandoni, Susan R Kahn
Apr 10, 2009·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·O HartungY S Alimi
Sep 30, 2010·Journal of Vascular Surgery·Michael A VasquezUNKNOWN American Venous Forum Ad Hoc Outcomes Working Group
Oct 12, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·G E RaskobUNKNOWN ISTH Steering Committee for World Thrombosis Day
Mar 5, 2015·Journal of Vascular and Interventional Radiology : JVIR·Rahmi OkluJoshua A Hirsch
Jan 19, 2016·Journal of Thrombosis and Thrombolysis·Suresh VedanthamNeil A Goldenberg
Feb 6, 2017·Thrombosis·Sasan BehraveshRahmi Oklu
Dec 7, 2017·The New England Journal of Medicine·Suresh VedanthamUNKNOWN ATTRACT Trial Investigators
Feb 6, 2018·Cardiovascular Diagnosis and Therapy·Drew FleckRahmi Oklu
Aug 8, 2018·Current Treatment Options in Cardiovascular Medicine·Ronald S Winokur, Akhilesh K Sista

❮ Previous
Next ❯

Citations

Jan 19, 2021·VASA. Zeitschrift für Gefässkrankheiten·Peter Franz Klein-WeigelLukas Beyer
Jul 23, 2021·Jornal Vascular Brasileiro·Fabio Henrique RossiAntônio Massamitsu Kambara

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation
percutaneous transluminal angioplasty

Software Mentioned

SPSS
ATTRACT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.